Q9DBQ7
Gene name |
Scyl3 (Pace1) |
Protein name |
Protein-associating with the carboxyl-terminal domain of ezrin |
Names |
Ezrin-binding protein PACE-1, SCY1-like protein 3 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:240880 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9DBQ7
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9DBQ7-F1 | Predicted | AlphaFoldDB |
31 variants for Q9DBQ7
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388511607 | 24 | L>R | No | EVA | |
| rs3390906273 | 29 | A>T | No | EVA | |
| rs3388512440 | 104 | I>F | No | EVA | |
| rs3388510634 | 248 | D>E | No | EVA | |
| rs3390938528 | 258 | S>I | No | EVA | |
| rs3390867519 | 263 | S>C | No | EVA | |
| rs3388514358 | 323 | G>E | No | EVA | |
| rs3388513070 | 325 | T>N | No | EVA | |
| rs3388514356 | 338 | V>M | No | EVA | |
| rs3388512142 | 339 | I>L | No | EVA | |
| rs3388512172 | 340 | P>H | No | EVA | |
| rs3388512163 | 392 | I>F | No | EVA | |
| rs3388514402 | 425 | A>S | No | EVA | |
| rs3388510350 | 451 | V>L | No | EVA | |
| rs46098542 | 457 | D>G | No | EVA | |
| rs48581078 | 457 | D>N | No | EVA | |
| rs3388512436 | 459 | S>L | No | EVA | |
| rs48653343 | 478 | R>C | No | EVA | |
| rs48653343 | 478 | R>S | No | EVA | |
| rs3388513018 | 483 | C>W | No | EVA | |
| rs254006804 | 521 | G>S | No | EVA | |
| rs240897855 | 532 | S>N | No | EVA | |
| rs3388512612 | 541 | P>H | No | EVA | |
| rs259032095 | 546 | R>I | No | EVA | |
| rs229196546 | 552 | C>W | No | EVA | |
| rs265686024 | 571 | D>G | No | EVA | |
| rs229695622 | 572 | G>C | No | EVA | |
| rs256009137 | 573 | E>Q | No | EVA | |
| rs211803377 | 574 | A>S | No | EVA | |
| rs46672857 | 703 | L>V | No | EVA | |
| rs247185616 | 725 | G>R | No | EVA |
No associated diseases with Q9DBQ7
1 regional properties for Q9DBQ7
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Protein kinase domain | 1 - 245 | IPR000719 |
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
| Golgi membrane | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| lamellipodium | A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| identical protein binding | Binding to an identical protein or proteins. |
| protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| neuron development | The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. |
| protein localization | Any process in which a protein is transported to, or maintained in, a specific location. |
| protein phosphorylation | The process of introducing a phosphate group on to a protein. |
| spinal cord motor neuron differentiation | The process in which neuroepithelial cells in the ventral neural tube acquire specialized structural and/or functional features of motor neurons. Motor neurons innervate an effector (muscle or glandular) tissue and are responsible for transmission of motor impulses from the brain to the periphery. Differentiation includes the processes involved in commitment of a cell to a specific fate. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGSENSALKS | YTLRESPFTL | PSGLAVYPAI | LQDGKCASVF | VYKRENEDKV | NKAAKHLKTL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| RHPCLLRFLS | CTVEADGIHL | VTERVQPLEV | ALETLSPAEV | CAGIYDILLA | LIFLHDRGHL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| THNNVCLSSV | FVSEDGHWKL | GGMETVCQVP | QATPEFLRNI | QSVRDPASIP | PEEMSPEFSG |
| 190 | 200 | 210 | 220 | 230 | 240 |
| LPESHGHARD | AYAFGALVDS | LLPIFNEQVS | ADVLSSFLQI | LHSALLNPMP | ECRPALSTLL |
| 250 | 260 | 270 | 280 | 290 | 300 |
| SHDFFRNDFL | EVVNFLKSLT | LKSEDEKTEF | FKFLLDRVSC | LSEELIASRL | VPLLLNQLVF |
| 310 | 320 | 330 | 340 | 350 | 360 |
| AEPVAVKSFL | PYLLGPKKEN | APGETPCLLS | PALFQSRVIP | VLLRLFEVHE | EHVRMVLLSH |
| 370 | 380 | 390 | 400 | 410 | 420 |
| IEAYVEHFTQ | EQLKKVILPQ | VLLGLRDTSN | SIVAITLRSL | AVLVSLLGPE | VVVGGERTKI |
| 430 | 440 | 450 | 460 | 470 | 480 |
| FKRTAPSFTK | TSDLSPEGSP | MHVVCSQQSR | VSKVLEDPSS | NVFPKWLSGN | VPSSSRKRIQ |
| 490 | 500 | 510 | 520 | 530 | 540 |
| EECYSSLSQT | GDQFSHTIKF | PMNGLSDVKN | TSEDNGSFPA | GSNKPEEWPD | WSEPEEPEQQ |
| 550 | 560 | 570 | 580 | 590 | 600 |
| PASIHRWPRE | PCDVAESQHT | NLTAEEVTWD | DGEASFGTEI | NSTATASAPV | PVTSGGQSTS |
| 610 | 620 | 630 | 640 | 650 | 660 |
| AALVPLTEES | KPLQSSPSSK | TSHRQHEEVK | PPQVSQERPL | KAPSGLGLGE | EFTIQVKKKP |
| 670 | 680 | 690 | 700 | 710 | 720 |
| VQDPELDWFA | DMIPEIKPSG | TFLILPELRT | EVMVPDKDNV | SSLMQFSSKF | AATEMTEGEA |
| 730 | |||||
| EGWEGEELAW | EDNNW |